Social differences in lung cancer management and survival in South East England: A cohort study

BMJ Open

Volumn 2, Issue 3, 2012, Pages

  Berglund, Anders ^a,b   Lambe, Mats ^a,b   Lüchtenborg, Margreet ^c   Linklater, Karen ^c   Peake, Michael D ^d,e   Holmberg, Lars ^b,c   Møller, Henrik ^c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d GLENFIELD HOSPITAL   (United Kingdom)

^e Portland House   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COHORT ANALYSIS; COMORBIDITY; FEMALE; HEALTH CARE SYSTEM; HUMAN; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; OUTCOME ASSESSMENT; POPULATION RESEARCH; PROGNOSIS; SOCIOECONOMICS; UNITED KINGDOM;

EID: 84863663808     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2012-001048     Document Type: Article

References (40)

1. Holmberg L, Sandin F, Bray F, et al. National comparisons of lung cancer survival in England, Norway and Sweden 2001-2004: differences occur early in follow-up. Thorax 2010;65:436-41.
2. Coleman MP, Forman D, Bryant H, et al. Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data. Lancet 2011;377:127-38.
3. Baldwin DR, White B, Schmidt-Hansen M, et al. Diagnosis and treatment of lung cancer: summary of updated NICE guidance. BMJ 2011;342:d2110.
4. Pearson FG. Current status of surgical resection for lung cancer. Chest 1994;106:337Se9S.
5. National Cancer Intelligence Network. NHS Treated Cancer Patients Receiving Major Surgical Resections - NCIN Briefing. London: National Cancer Intelligence Network Coordinating Centre, 2010.
6. Fry WA, Phillips JL, Menck HR. Ten-year survey of lung cancer treatment and survival in hospitals in the United States: a national cancer data base report. Cancer 1999;86:1867-76. (Pubitemid 29513058)
7. Myrdal G, Lamberg K, Lambe M, et al. Regional differences in treatment and outcome in non-small cell lung cancer: a population-based study (Sweden). Lung Cancer 2009;63:16-22.
8. Riaz SP, Horton M, Kang J, et al. Lung cancer incidence and survival in England: an analysis by socioeconomic deprivation and urbanization. J Thorac Oncol 2011;1:1.
9. Jack RH, Davies EA, Moller H. Lung cancer incidence and survival in different ethnic groups in South East England. Br J Cancer 2011;105:1049-53.
10. Coleman MP, Rachet B, Woods LM, et al. Trends and socioeconomic inequalities in cancer survival in England and Wales up to 2001. Br J Cancer 2004;90:1367-73. (Pubitemid 38586262)
11. Jack RH, Gulliford MC, Ferguson J, et al. Geographical inequalities in lung cancer management and survival in South East England: evidence of variation in access to oncology services? Br J Cancer 2003;88:1025-31. (Pubitemid 36560769)
12. NHS Information Centre. The National Lung Cancer Audit: 2011 Report. http://www.ic.nhs.uk/webfiles/Services/NCASP/audits%20and%20reports/ NHS-IC-Lung-Cancer-AUDIT-2011-Interactive- PDF-V1.0.pdf (accessed 15 Jan 2012).
13. Department of Health. The NHS Cancer Plan: A Plan for Investment, A Plan for Reform. London, Department of Health, 2000.
14. Rachet B, Ellis L, Maringe C, et al. Socioeconomic inequalities in cancer survival in England after the NHS cancer plan. Br J Cancer 2010;103:446-53.
15. McMahon M, Barbiere JM, Greenberg DC, et al. Population-based trends in use of surgery for non-small cell lung cancer in a UK region, 1995-2006. Thorax 2011;66:453-5.
16. Berglund A, Holmberg L, Tishelman C, et al. Social inequalities in non-small cell lung cancer management and survival: a population-based study in central Sweden. Thorax 2010;65:327-33.
17. The NHS Information Centre. National Lung Cancer Audit 2010. Leeds: The NHS Information Centre for Health and Social Care, 2009.
18. National Cancer Intelligence Network. National Cancer Data Repository. http://www.ncin.org.uk/collecting-and-using-data/national-cancer-data- repository/default.aspx
19. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-83. (Pubitemid 17055592)
20. Berglund A, Garmo H, Tishelman C, et al. Comorbidity, treatment and mortality: a population based cohort study of prostate cancer in PCBaSe Sweden. J Urol 2011;185:833-9.
21. Janssen-Heijnen ML, Smulders S, Lemmens VE, et al. Effect of comorbidity on the treatment and prognosis of elderly patients with non-small cell lung cancer. Thorax 2004;59:602-7. (Pubitemid 38901520)
22. Department of Communities and Local Government. Indices of Deprivation 2007. http://www.communities.gov.uk/publications/communities/ indicesdeprivation07.
23. White IR, Royston P, Wood AM. Multiple imputation using chained equations: issues and guidance for practice. Stat Med 2011;30:377-99.
24. Royston P, Parmar MK. Flexible parametric proportional-hazards and proportional-odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects. Stat Med 2002;21:2175-97. (Pubitemid 34830755)
25. Lambert PC, Royston P. Further development of flexible parametric models for survival analysis. Stata J 2009;9:265-90.
26. Team R.D.C. R: A Language and Environment for Statistical Computing. Vienna Austria: R Foundation for Statistical Computing, 2008.
27. Asmis TR, Ding K, Seymour L, et al. Age and comorbidity as independent prognostic factors in the treatment of non small-cell lung cancer: a review of National Cancer Institute of Canada Clinical Trials Group trials. J Clin Oncol 2008;26:54-9.
28. Travis WD. Reporting lung cancer pathology specimens. Impact of the anticipated 7th Edition TNM classification based on recommendations of the IASLC Staging Committee. Histopathology 2009;54:3-11.
29. Smith GD, Hart C, Watt G, et al. Individual social class, area-based deprivation, cardiovascular disease risk factors, and mortality: the Renfrew and Paisley Study. J Epidemiol Community Health 1998;52:399-405. (Pubitemid 28438526)
30. Smith GD, Hart C. Re: "Use of census based aggregate variables to proxy for socioeconomic group: evidence from national samples". Am J Epidemiol 1999;150:996-7.
31. Louwman WJ, Aarts MJ, Houterman S, et al. A 50% higher prevalence of life-shortening chronic conditions among cancer patients with low socioeconomic status. Br J Cancer 2010;103:1742-8.
32. Dalton SO, Frederiksen BL, Jacobsen E, et al. Socioeconomic position, stage of lung cancer and time between referral and diagnosis in Denmark, 2001-2008. Br J Cancer 2011;105:1042-8.
33. Halpern MT, Ward EM, Pavluck AL, et al. Association of insurance status and ethnicity with cancer stage at diagnosis for 12 cancer sites: a restrospective analysis. Lancet Oncol 2008;9:222-31.
34. Riaz SP, Luchtenborg M, Jack RH, et al. Variation in surgical resection for lung cancer in relation to survival: population-based study in England 2004-2006. Eur J Cancer 2011;24:24.
35. Patel N, Adaita R, Mellemgaard A, et al. Variation in the use of chemotherapy in lung cancer. Br J Cancer 2007;96:886-90. (Pubitemid 46452290)
36. Bungay H. Cancer and health policy: the postcode lottery of care. Soc Pol Admin 2005;39:35-48. (Pubitemid 40191288)
37. Crawford SM, Sauerzapf V, Haynes R, et al. Social and geographical factors affecting access to treatment of lung cancer. Br J Cancer 2009;101:897-901.
38. Kogevinas M, Pearce N, Susser M, et al. Social Inequalities and Cancer. Vol. 138. Lyon: IARC Scientific Publications, International Agency for Research on Cancer, 1997.
39. Brewster DH, Thomson CS, Hole DJ, et al. Relation between socioeconomic status and tumour stage in patients with breast, colorectal, ovarian, and lung cancer: results from four national, population based studies. BMJ 2001; 322:830-1. (Pubitemid 32291133)
40. Feinstein AR, Sosin DM, Wells CK. The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med 1985;312:1604-8. (Pubitemid 15062653)